07/01/2025 11:15 PM | Inozyme Pharma (Filer)
| Form EFFECT | |
07/01/2025 11:15 PM | Inozyme Pharma (Filer)
| Form EFFECT | |
07/01/2025 8:29 AM | Inozyme Pharma (Filer)
| Form POS AM | |
07/01/2025 8:43 AM | Inozyme Pharma (Filer)
| Form S-8 POS | |
07/01/2025 8:44 AM | Inozyme Pharma (Filer)
| Form S-8 POS | |
07/01/2025 8:45 AM | Inozyme Pharma (Filer)
| Form S-8 POS | |
07/01/2025 8:48 AM | Inozyme Pharma (Filer)
| Form S-8 POS | |
07/01/2025 8:49 AM | Inozyme Pharma (Filer)
| Form S-8 POS | |
07/01/2025 8:51 AM | Inozyme Pharma (Filer)
| Form S-8 POS | |
07/01/2025 8:54 AM | Inozyme Pharma (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
07/01/2025 8:18 AM | BIOMARIN PHARMACEUTICAL INC (Filed by) Inozyme Pharma (Subject)
| Form SC TO-T/A | |
Get the Latest News and Ratings for INZY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter.
|
07/01/2025 8:21 AM | Inozyme Pharma (Subject)
| Form SC 14D9/A | |
07/01/2025 8:25 AM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/01/2025 8:27 AM | Inozyme Pharma (Filer)
| Form POS AM | |
06/20/2025 6:29 PM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2025 6:31 PM | Inozyme Pharma (Filer)
| Form DEFA14A | |
06/17/2025 6:28 AM | BIOMARIN PHARMACEUTICAL INC (Filed by) Inozyme Pharma (Subject)
| Form SC TO-T/A | |
06/17/2025 5:15 AM | Inozyme Pharma (Subject)
| Form SC 14D9/A | |
06/04/2025 4:09 PM | GLAZER CAPITAL, LLC (Filed by) Inozyme Pharma (Subject)
| Form SCHEDULE 13G | |
06/04/2025 3:51 PM | Inozyme Pharma (Subject)
| Form SC 14D9/A | |
06/04/2025 3:32 PM | BIOMARIN PHARMACEUTICAL INC (Filed by) Inozyme Pharma (Subject)
| Form SC TO-T/A | |
06/02/2025 6:35 AM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2025 6:14 AM | Inozyme Pharma (Subject)
| Form SC 14D9 | |
06/02/2025 5:25 AM | BIOMARIN PHARMACEUTICAL INC (Filed by) Inozyme Pharma (Subject)
| Form SC TO-T | |
05/30/2025 4:24 PM | Affinity Asset Advisors, LLC (Filed by) Inozyme Pharma (Subject)
| Form SCHEDULE 13G/A | |
05/19/2025 8:23 PM | Inozyme Pharma (Subject)
| Form SC14D9C | |
05/19/2025 4:22 PM | BIOMARIN PHARMACEUTICAL INC (Filed by) Inozyme Pharma (Subject)
| Form SC TO-C | |
05/16/2025 8:44 PM | BIOMARIN PHARMACEUTICAL INC (Filed by) Inozyme Pharma (Subject)
| Form SC TO-C | |
05/16/2025 4:16 PM | BIOMARIN PHARMACEUTICAL INC (Filed by) Inozyme Pharma (Subject)
| Form SC TO-C | |
05/16/2025 3:40 PM | Inozyme Pharma (Subject)
| Form SC14D9C | |
05/16/2025 7:06 AM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2025 6:33 AM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2025 6:36 AM | Inozyme Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025 9:28 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by) Inozyme Pharma (Subject)
| Form SCHEDULE 13G/A | |
04/03/2025 3:27 PM | Inozyme Pharma (Issuer) Treco Douglas A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2025 3:27 PM | Inozyme Pharma (Issuer) Subramanian Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2025 3:29 PM | Inozyme Pharma (Issuer) Winton Matthew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 3:24 PM | Inozyme Pharma (Issuer) Treco Douglas A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 3:25 PM | Inozyme Pharma (Issuer) Winton Matthew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/17/2025 3:26 PM | Inozyme Pharma (Issuer) Subramanian Sanjay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 4:17 PM | Inozyme Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad) This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto.
Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave. Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin |
03/10/2025 7:31 AM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/10/2025 7:31 AM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/10/2025 7:32 AM | Inozyme Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/10/2025 7:32 AM | Inozyme Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2025 12:59 PM | Inozyme Pharma (Subject) SAMLYN CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/10/2025 7:06 AM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 11:19 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by) Inozyme Pharma (Subject)
| Form SC 13G/A | |
11/05/2024 7:33 AM | Inozyme Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024 7:31 AM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 3:34 PM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 1:02 PM | BlackRock, Inc. (Filed by) Inozyme Pharma (Subject)
| Form SC 13G | |
10/03/2024 7:58 PM | Inozyme Pharma (Issuer) Treco Douglas A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/03/2024 7:57 PM | Inozyme Pharma (Issuer) Winton Matthew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 3:52 PM | Inozyme Pharma (Filer)
| Form 424B5 | |
08/06/2024 3:54 PM | Inozyme Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |